Skip to main content
Shop Plans Learn more about our coverage options including health, Medicare, dental and vision options for you, your family or your employees. Get Started Individual & Family Medicare Employer Vision Dental International Travel Find Care FAQ Blog Members Stay on top of your health care with helpful member resources. Members Home Medicare Health Dental Vision Find Care Member Knowledge Center Member Forms Medicare Forms Library Make a Payment Federal Employees Student Blue Healthy Blue Providers Access tools, policies and the latest information to help you care for our members. Providers Home Network Participation Networks & Programs Claims, Appeals & Inquiries Prior Authorization Services & CPT codes Prescription Drug Search Policies, Guidelines & Codes Provider News Provider FAQ Contact Us Employers Learn about our coverage options for small and large employers, and access tools and resources for your group. Employers Home Shop Employer Plans Employer Portal Support Member Forms & Resources Find Care Blog Agents Access the tools you need: rate quotes, applications, forms, the latest industry news, marketing materials and more. Agents Home Agent Services Check Eligibility Find Care Member Forms & Resources Medicare Forms Library
Contact Us
Log In
I am ... Please select A member A provider An employer An agent
Log in to Agent Services
Log in to Employer Services Register for Employer Services I'm registered but need portal access
Username Forgot username? Continue to Log In Register for Blue Connect Need help? Learn how to log in.
Log in to Blue e Register for Blue e Log in to Dental Blue
Back
Medical Policies and Clinical Utilization Management Guidelines Update May 26, 2021 Medical Policy & Clinical Guidelines

Please note, this communication applies to Healthy Blue + Medicare (HMO D-SNP) offered by Blue Cross and Blue Shield of North Carolina (Blue Cross NC).

The Medical Policies, Clinical Utilization Management (UM) Guidelines and Third Party Criteria below were developed and/or revised to support clinical coding edits. Note, several policies and guidelines were revised to provide clarification only and are not included. Existing precertification requirements have not changed. Please note: The Medical Policies and Clinical UM Guidelines below are followed in the absence of Medicare guidance.

Please share this notice with other members of your practice and office staff.

To view a guideline, visit https://medpol.providers.amerigroup.com/green-provider/medical-policies-and-clinical-guidelines-full-list.

 

Notes/Updates:

Updates marked with an asterisk (*) notate that the criteria may be perceived as more restrictive.

  • *CG-LAB-15 – Red Blood Cell Folic Acid Testing
    • RBC folic acid testing is considered not medically necessary in all cases
  • *CG-LAB-16 – Serum Amylase Testing
    • Serum amylase testing is considered not medically necessary for acute and chronic pancreatitis and all other conditions
  • *CG-GENE-04 – Molecular Marker Evaluation of Thyroid Nodules
    • Added the Afirma Xpression Atlas as not medically necessary
  • SURG.00158 – Implantable Peripheral Nerve Stimulation Devices as a Treatment for Pain
    • new Medical Policy was created from content contained in DME.00011
    • There are no changes to the policy content.
    • Publish date is December 16, 2020.
  • CG-GENE-21 – Cell-Free Fetal DNA-Based Prenatal Testing
    • new Clinical Guideline was created from content contained in GENE.00026
    • There are no changes to the guideline content.
    • Publish date is December 16, 2020.

Medical Policies

On November 5, 2020, the Medical Policy and Technology Assessment Committee (MPTAC) approved the following Medical Policies applicable to Blue Cross NC. These guidelines take effect June 8, 2021. 

PUBLISH DATE

MEDICAL POLICY NUMBER

MEDICAL POLICY TITLE

NEW OR REVISED

11/12/2020

ANC.00009

Cosmetic and Reconstructive Services of the Trunk and Groin

Revised

11/12/2020

GENE.00052

Whole Genome Sequencing, Whole Exome Sequencing, Gene Panels, and Molecular Profiling

Revised

11/12/2020

MED.00129

Gene Therapy for Spinal Muscular Atrophy

Revised

12/16/2020

SURG.00011

Allogeneic, Xenographic, Synthetic and Composite Products for Wound Healing and Soft Tissue Grafting

Revised

Clinical UM Guidelines

On November 5, 2020, the MPTAC approved the following Clinical UM Guidelines applicable to Blue Cross NC. These guidelines adopted by the medical operations committee for Blue Cross NC members on November 19, 2020. These guidelines take effect June 8, 2021.

PUBLISH DATE

CLINICAL UM GUIDELINE NUMBER

CLINICAL UM GUIDELINE TITLE

NEW OR REVISED

12/16/2020

*CG-LAB-15

Red Blood Cell Folic Acid Testing

New

12/16/2020

*CG-LAB-16

Serum Amylase Testing

New

11/12/2020

CG-DME-42

Non-implantable Insulin Infusion and Blood Glucose Monitoring Devices

Revised

12/16/2020

*CG-GENE-04

Molecular Marker Evaluation of Thyroid Nodules

Revised

12/16/2020

CG-GENE-18

Genetic Testing for TP53 Mutations

Revised

12/16/2020

CG-GENE-20

Epidermal Growth Factor Receptor (EGFR) Testing

Revised

11/12/2020

CG-MED-87

Single Photon Emission Computed Tomography Scans for Noncardiovascular Indications

Revised